CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
78.24
+0.32 (0.41%)
Mar 9, 2026, 4:00 PM EDT - Market closed
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,768 | 4,614 | 8,344 | 4,311 | 8,001 | Upgrade
|
| Depreciation & Amortization | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 | Upgrade
|
| Loss (Gain) From Sale of Assets | -247 | - | 349 | 2,058 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 5,725 | 840 | 152 | - | 1,789 | Upgrade
|
| Stock-Based Compensation | 535 | 540 | 588 | 447 | 484 | Upgrade
|
| Other Operating Activities | -274 | -1,593 | -388 | -1,681 | -352 | Upgrade
|
| Change in Accounts Receivable | -3,498 | -1,301 | -6,260 | -2,971 | -2,703 | Upgrade
|
| Change in Inventory | -1,267 | -102 | 1,233 | -1,435 | 735 | Upgrade
|
| Change in Accounts Payable | 3,855 | 2,335 | 3,618 | 4,260 | 2,898 | Upgrade
|
| Change in Other Net Operating Assets | -564 | -823 | 1,424 | 6,964 | 2,927 | Upgrade
|
| Operating Cash Flow | 10,639 | 9,107 | 13,426 | 16,177 | 18,265 | Upgrade
|
| Operating Cash Flow Growth | 16.82% | -32.17% | -17.01% | -11.43% | 15.13% | Upgrade
|
| Capital Expenditures | -2,832 | -2,781 | -3,031 | -2,727 | -2,520 | Upgrade
|
| Cash Acquisitions | -436 | -95 | -16,612 | -139 | -146 | Upgrade
|
| Divestitures | - | - | - | -1,249 | - | Upgrade
|
| Investment in Securities | -2,629 | -4,838 | -1,314 | -1,017 | -2,717 | Upgrade
|
| Other Investing Activities | 26 | 101 | 68 | 85 | 122 | Upgrade
|
| Investing Cash Flow | -5,871 | -7,613 | -20,889 | -5,047 | -5,261 | Upgrade
|
| Short-Term Debt Issued | - | 1,919 | 5,200 | - | - | Upgrade
|
| Long-Term Debt Issued | 3,969 | 7,913 | 10,898 | - | 987 | Upgrade
|
| Total Debt Issued | 3,969 | 9,832 | 16,098 | - | 987 | Upgrade
|
| Short-Term Debt Repaid | -2,119 | - | -5,000 | - | - | Upgrade
|
| Long-Term Debt Repaid | -3,629 | -4,773 | -3,166 | -4,211 | -10,254 | Upgrade
|
| Total Debt Repaid | -5,748 | -4,773 | -8,166 | -4,211 | -10,254 | Upgrade
|
| Net Debt Issued (Repaid) | -1,779 | 5,059 | 7,932 | -4,211 | -9,267 | Upgrade
|
| Issuance of Common Stock | 394 | 361 | 277 | 551 | 549 | Upgrade
|
| Repurchase of Common Stock | -158 | -3,208 | -2,193 | -3,870 | -168 | Upgrade
|
| Common Dividends Paid | -3,397 | -3,373 | -3,132 | -2,907 | -2,625 | Upgrade
|
| Other Financing Activities | - | 26 | -201 | -79 | 155 | Upgrade
|
| Financing Cash Flow | -4,940 | -1,135 | 2,683 | -10,516 | -11,356 | Upgrade
|
| Net Cash Flow | -172 | 359 | -4,780 | 614 | 1,648 | Upgrade
|
| Free Cash Flow | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 | Upgrade
|
| Free Cash Flow Growth | 23.41% | -39.14% | -22.71% | -14.58% | 17.26% | Upgrade
|
| Free Cash Flow Margin | 1.95% | 1.71% | 2.92% | 4.18% | 5.41% | Upgrade
|
| Free Cash Flow Per Share | 6.14 | 5.01 | 8.06 | 10.17 | 11.85 | Upgrade
|
| Cash Interest Paid | 2,991 | 2,909 | 2,418 | 2,239 | 2,469 | Upgrade
|
| Cash Income Tax Paid | 2,166 | 1,703 | 3,524 | 4,116 | 3,195 | Upgrade
|
| Levered Free Cash Flow | 5,930 | 6,909 | 11,075 | 11,935 | 14,783 | Upgrade
|
| Unlevered Free Cash Flow | 7,879 | 8,758 | 12,737 | 13,365 | 16,347 | Upgrade
|
| Change in Working Capital | -1,474 | 109 | 15 | 6,818 | 3,857 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.